Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
U.S. NeuroSurgical Holdings, Inc. (USNU)
|
|
Income Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K/A | 10-Q | 10-Q |
Revenue | | | | | | | | |
Revenue growth | | | | | -100.0% | -100.0% | -100.0% | -100.0% |
Costs and expenses: | | | | | | | | |
Selling, general and administrative | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 0.3 | 0.2 |
Total | 0.2 | 0.1 | 0.2 | 0.3 | 0.4 | 0.2 | 0.3 | 0.2 |
Operating loss | -0.2 | -0.1 | -0.2 | -0.3 | -0.4 | -0.2 | -0.3 | -0.2 |
Operating margin | | | | | | | | |
|
Total other expense | | | | | | | | |
Loss from investments in unconsolidated entities, net | -0.3 | 0.0 | -0.2 | -1.0 | -0.1 | -0.1 | -0.1 | -0.1 |
Total other expense | -0.3 | 0.0 | -0.2 | -1.0 | -0.1 | -0.5 | -0.1 | -0.1 |
(Loss) income before income taxes | -0.5 | -0.1 | -0.4 | -1.3 | -0.5 | -0.4 | -0.3 | -0.4 |
Provision for income taxes | | | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | -0.2 |
Net (loss) income | -0.5 | -0.1 | -0.4 | -1.3 | -0.5 | -1.0 | -0.4 | -0.6 |
Net loss attributable to noncontrolling interests | 0.1 | 0.0 | 0.1 | 0.2 | 0.1 | 0.1 | | |
Net (loss) income attributable to U.S. Neurosurgical Holdings, Inc. | -0.4 | -0.1 | -0.3 | -1.1 | -0.4 | -0.5 | -0.4 | -0.6 |
|
Basic net | ($0.05) | ($0.01) | ($0.04) | ($0.14) | ($0.05) | ($0.06) | ($0.05) | ($0.08) |
Diluted net | ($0.05) | ($0.01) | ($0.04) | ($0.14) | ($0.05) | ($0.06) | ($0.05) | ($0.08) |
|
Weighted average common shares outstanding, basic (in shares) | 7.9 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Weighted average common shares outstanding, diluted (in shares) | 7.9 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
|